253 related articles for article (PubMed ID: 27351768)
21. Outcome of acute myeloid leukemia and high-risk myelodysplastic syndrome according to health insurance status.
Al-Ameri A; Anand A; Abdelfatah M; Kanaan Z; Hammonds T; Haller N; Cherry M
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):509-13. PubMed ID: 25108681
[TBL] [Abstract][Full Text] [Related]
22. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457
[TBL] [Abstract][Full Text] [Related]
25. Outcomes and quality of care in acute myeloid leukemia over 40 years.
Alibhai SM; Leach M; Minden MD; Brandwein J
Cancer; 2009 Jul; 115(13):2903-11. PubMed ID: 19452536
[TBL] [Abstract][Full Text] [Related]
26. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
Sedeta E; Jemal A; Nisotel L; Sung H
Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
Dharmani C; Wang E; Tu N; Salas M; Kamel YM
Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
29. A Retrospective Study of Comorbidities and Complications in Elderly Acute Myeloid Leukemia Patients in the United States.
Dhopeshwarkar N; Iqbal S; Wang X; Salas M
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e436-e456. PubMed ID: 31129110
[TBL] [Abstract][Full Text] [Related]
30. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
Jabo B; Morgan JW; Martinez ME; Ghamsary M; Wieduwilt MJ
PLoS One; 2017; 12(4):e0174760. PubMed ID: 28384176
[TBL] [Abstract][Full Text] [Related]
31. Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.
Zeidner JF; Karp JE; Blackford AL; Foster MC; Dees EC; Smith G; Ivy SP; Harris P
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26553781
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
[TBL] [Abstract][Full Text] [Related]
33. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
34. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.
Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Polychronopoulou S; Stiakaki E; Moschovi M; Hatzipantelis E; Kourti M; Graphakos S; Pombo-de-Oliveira MS; Adami HO; Petridou ET
Eur J Cancer; 2016 Nov; 67():183-190. PubMed ID: 27677054
[TBL] [Abstract][Full Text] [Related]
35. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
37. Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.
Østgård LSG; Nørgaard M; Medeiros BC; Friis LS; Schoellkopf C; Severinsen MT; Marcher CW; Nørgaard JM
J Clin Oncol; 2017 Nov; 35(32):3678-3687. PubMed ID: 28892433
[TBL] [Abstract][Full Text] [Related]
38. Acute leukemia in patients sixty years of age and older: a twenty year single institution review.
Leger CS; Leitch HA; Galbraith PF; Li CH; Vickars LM
Am J Clin Oncol; 2009 Apr; 32(2):137-41. PubMed ID: 19307947
[TBL] [Abstract][Full Text] [Related]
39. A population-based study of the epidemiology and clinical features of adults with acute myeloid leukemia in Algeria: report on behalf of the Algerian Acute Leukemia Study Group.
Bekadja MA; Hamladji RM; Belhani M; Ardjoun FZ; Abad MT; Touhami H; Ait-Ali H; Zouaoui Z; Sidimansour N; Hamdi S; Grifi F; Mesli N; Saidi M; Mehalhal N; Bachiri A; Bouhass R; Said YM; Midoun N
Hematol Oncol Stem Cell Ther; 2011; 4(4):161-6. PubMed ID: 22198187
[TBL] [Abstract][Full Text] [Related]
40. Outcome disparities by insurance type for patients with acute myeloblastic leukemia.
Pulte D; Castro FA; Brenner H; Jansen L
Leuk Res; 2017 May; 56():75-81. PubMed ID: 28212899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]